Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

RFK Jr. fumbles Medicare basics during second confirmation hearing
BioPharma Dive
Thursday, January 30, 2025 - 11:32pm
tags:
Robert F Kennedy Jr., HHS, Senate, Medicare
Vabysmo crosses $4B mark, Polivy joins blockbuster club as Roche preps for key readouts
Fierce Pharma
Thursday, January 30, 2025 - 11:30pm
tags:
Roche, Polivy, Vabysmo, earnings
Regeneron patents block biosimilar entry for Eylea
Patently-O
Thursday, January 30, 2025 - 11:26pm
tags:
Regeneron, Eylea, legal, biosimilars, patents
Novartis to Make Super Bowl 2025 Debut with Breast Cancer Commercial
Xtalks
Thursday, January 30, 2025 - 11:24pm
tags:
Novartis, breast cancer, Super Bowl, DTC advertising, television ads
Novo Nordisk commences fresh trials for CagriSema
Devdiscourse
Thursday, January 30, 2025 - 11:33am
tags:
Novo Nordisk, CagriSema, clinical trials, obesity
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
Beckers Hospital Review
Thursday, January 30, 2025 - 11:28am
tags:
PBMs, Express Scripts, Mark Cuban
FDA protocol deviation guidance could go further
Clinical Trials Arena
Thursday, January 30, 2025 - 11:05am
tags:
FDA, clinical trials, regulatory
Imvax secures $29m to support Phase IIb glioblastoma therapy trial
Clinical Trials Arena
Thursday, January 30, 2025 - 11:03am
tags:
Imvax, IGV-001, glioblastoma, clinical trials, funding
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Fierce Pharma
Thursday, January 30, 2025 - 10:58am
tags:
Merck, clinical trials, Winrevair, PAH
Sanofi Plans €5 Billion Buyback, Sees Higher Profit Growth
Yahoo/Bloomberg
Thursday, January 30, 2025 - 10:55am
tags:
Sanofi, earnings
Shionogi's RSV antiviral reduces viral load in phase 2 trial of adults
Fierce Biotech
Thursday, January 30, 2025 - 10:53am
tags:
Shionogi, RSV, clinical trials, S-337395
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo
Clinical Trials Arena
Thursday, January 30, 2025 - 10:52am
tags:
ImmunityBio, BeiGene, clinical trials, tislelizumab, anktiva, advanced non-small cell lung cancer, metastatic non-small cell lung cancer
4 robotic surgery trends to watch in 2025
Medtech Dive
Thursday, January 30, 2025 - 10:51am
tags:
robotic surgery, Medtech, Intuitive Surgical, Medtronic, CMR Surgical, Moon Surgical
Executive hiring changes reflect a broader biotech comeback
Pharma Voice
Thursday, January 30, 2025 - 10:49am
tags:
biotech, executives
Takeda CEO succession confirmed as Weber plans retirement
Pharmaphorum
Thursday, January 30, 2025 - 10:48am
tags:
Takeda, Pharma CEOs, Christophe Weber, Julie Kim
RFK Jr. denies being anti-vaccine during intense Senate confirmation
Clinical Trials Arena
Wednesday, January 29, 2025 - 7:29pm
tags:
Robert F Kennedy Jr., HHS, Senate, vaccines, Donald Trump
Stryker Goes Spineless
Medical Devices and Diagnostics Industry
Wednesday, January 29, 2025 - 7:28pm
tags:
Medtech, Stryker, spinal impants
Teva, despite delivering in 2024, startles investors with subdued 2025 guidance
Fierce Pharma
Wednesday, January 29, 2025 - 7:27pm
tags:
Teva Pharmaceutical, Richard Francis, Pharma CEOs
New Zepbound TV Commercial Inspires ‘Change’
Xtalks
Wednesday, January 29, 2025 - 7:25pm
tags:
Eli Lilly, Zepbound, DTC advertising, television ads
Inhibikase Halts Parkinson's Drug Development to Focus on PAH
Investing.com
Wednesday, January 29, 2025 - 7:22pm
tags:
Inhibikase Therapeutics, Parkinson's Disease, risvodetinib, PAH

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.